Register now for unlimited free access!

A valid email address. All emails from the system will be sent to this address. The email address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by email.
Several special characters are allowed, including space, period (.), hyphen (-), apostrophe ('), underscore (_), and the @ sign.
Provide a password for the new account in both fields.
Zipcode
Back to top

Diagnostic criteria for 292.89 Inhalant Intoxication

These criteria are obsolete.

DSM Criteria
DSM Version
DSM IV - TR
DSM Criteria

A. Recent intentional use or short-term, high-dose exposure to volatile inhalants (excluding anesthetic gases and short-acting vasodilators). 

B. Clinically significant maladaptive behavioral or psychological changes (e.g., belligerence, assaultiveness, apathy, impaired judgment, impaired social or occupational functioning) that developed during, or shortly after, use of or exposure to volatile inhalants. 

C. Two (or more) of the following signs, developing during, or shortly after, inhalant use or exposure: 

(1) dizziness 
(2) nystagmus 
(3) incoordination 
(4) slurred speech 
(5) unsteady gait 
(6) lethargy 
(7) depressed reflexes 
(8) psychomotor retardation 
(9) tremor 
(10) generalized muscle weakness 
(11) blurred vision or diplopia 
(12) stupor or coma 
(13) euphoria

D. The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder.

Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Copyright 2000 American Psychiatric Association

DSM Version
DSM IV
DSM Criteria

A. Recent intentional use or short-term, high-dose exposure to volatile inhalants (excluding anesthetic gases and short-acting vasodilators). 

B. Clinically significant maladaptive behavioral or psychological changes (e.g., belligerence, assaultiveness, apathy, impaired judgment, impaired social or occupational functioning) that developed during, or shortly after, use of or exposure to volatile inhalants. 

C. Two (or more) of the following signs, developing during, or shortly after, inhalant use or exposure: 

(1) dizziness 
(2) nystagmus 
(3) incoordination 
(4) slurred speech 
(5) unsteady gait 
(6) lethargy 
(7) depressed reflexes 
(8) psychomotor retardation 
(9) tremor 
(10) generalized muscle weakness 
(11) blurred vision or diplopia 
(12) stupor or coma 
(13) euphoria

D. The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder.

Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Copyright 1994 American Psychiatric Association